2000
Cervical Neoplasia and Repeated Positivity of Human Papillomavirus Infection In Human Immunodeficiency Virus-seropositive and -seronegative Women
Ahdieh L, Munoz A, Vlahov D, Trimble C, Timpson L, Shah K. Cervical Neoplasia and Repeated Positivity of Human Papillomavirus Infection In Human Immunodeficiency Virus-seropositive and -seronegative Women. American Journal Of Epidemiology 2000, 151: 1148-1157. PMID: 10905527, DOI: 10.1093/oxfordjournals.aje.a010165.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntiviral AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHIV SeronegativityHIV SeropositivityHumansImmunosuppression TherapyIncidenceLongitudinal StudiesPapillomaviridaePapillomavirus InfectionsRisk AssessmentSurvival AnalysisTumor Virus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsConceptsCervical intraepithelial neoplasiaHuman papillomavirus infectionHPV positivityHPV clearancePapillomavirus infectionHIV infectionBiopsy-confirmed cervical intraepithelial neoplasiaAssociation of HIVPotent antiretroviral therapyCervicovaginal lavage specimensHuman immunodeficiency virusCells/Reversal of immunosuppressionPolymerase chain reaction-based assaySeronegative womenAntiretroviral therapyHIV- womenHPV resultsHIV- participantsHPV DNACervical neoplasiaHIV serostatusIntraepithelial neoplasiaImmunodeficiency virusRelated immunosuppression
1999
Prevalence of Lower Genital Tract Infections Among Human Immunodeficiency Virus (HIV)—Seropositive and High-Risk HIV-Seronegative Women
Cu-Uvin S, Hogan J, Warren D, Klein R, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, Mayer K, Group F. Prevalence of Lower Genital Tract Infections Among Human Immunodeficiency Virus (HIV)—Seropositive and High-Risk HIV-Seronegative Women. Clinical Infectious Diseases 1999, 29: 1145-1150. PMID: 10524955, DOI: 10.1086/313434.Peer-Reviewed Original ResearchConceptsHIV-seronegative womenGenital tract infectionLower genital tract infectionHuman immunodeficiency virusTract infectionsBacterial vaginosisImmunodeficiency virusHigh-risk HIV-seronegative womenLower Genital Tract InfectionsRisk HIV-seronegative womenHuman papilloma virus infectionHIV-seropositive womenPapilloma virus infectionHigh-risk womenNeisseria gonorrhoeae infectionChlamydia trachomatis infectionHIV Epidemiology Research StudySimilar HIVSeropositive womenGonorrhoeae infectionBaseline visitTrachomatis infectionCandidal vaginitisVirus infectionInfection
1997
Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection
Shah K, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. Journal Of Clinical Microbiology 1997, 35: 517-519. PMID: 9003632, PMCID: PMC229616, DOI: 10.1128/jcm.35.2.517-519.1997.Peer-Reviewed Original ResearchConceptsHuman papillomavirusHybrid captureInjection drug-using womenHuman immunodeficiency virus (HIV) infectionL1 consensus primersHIV-negative womenImmunodeficiency virus infectionPap smear abnormalitiesHuman immunodeficiency virusDrug-using womenHPV prevalencePositive womenSmear abnormalitiesImmunodeficiency virusViral loadHybrid capture methodVirus infectionHigh riskComparison of PCRLow specificityConsensus primersWomenPapillomavirusPCRInfection